Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

NCT06107868 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Ovarian Cancer
Recurrent Uterine Cancer
Metastatic Cancer
Advanced Cancer

Interventions

DRUG: RP-6306
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

University Health Network, Toronto